Oncotype DX - An Educational Guide by Genomic Health

Have you recently been diagnosed with early-stage invasive breast cancer? Are you struggling to make treatment decisions? If so, you may be interested to know that not all women with early-stage breast cancer benefit from chemotherapy. Oncotype DX test helps identify which women with early-stage, estrogen receptor-positive (ER+) invasive breast cancer are more likely to benefit from adding chemotherapy to their hormonal treatment.